Testing effectiveness (Phase 2)Study completedNCT01842646
What this trial is testing
Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)
Who this might be right for
Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)
H. Lee Moffitt Cancer Center and Research Institute 35